licensing

RAKEZ Participates in Shanghai Licensing Expo

• .

RAKEZ Participates in Shanghai Licensing Expo

NewsVoir 18 July، 2024

Ras Al Khaimah, United Arab Emirates Ras Al Khaimah Economic Zone (RAKEZ) is participating in this year’s...

Read More Read more about RAKEZ Participates in Shanghai Licensing Expo

Hoffmann Green Signs a Key Licensing Agreement in the United States

• miscellaneous news

Hoffmann Green Signs a Key Licensing Agreement in the United States

AETOSWire 10 July، 2024

Entrance fees of €20 million, including 2 million guaranteed Business model including entrance fees, royalties and the...

Read More Read more about Hoffmann Green Signs a Key Licensing Agreement in the United States

Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa

• .

Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa

AETOSWire 13 October، 2023

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive license...

Read More Read more about Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa

Hikma and Cosmo partner on exclusive licensing agreement for Winlevi® (Clascoterone) for the Middle East and North Africa

• Health and Beauty

Hikma and Cosmo partner on exclusive licensing agreement for Winlevi® (Clascoterone) for the Middle East and North Africa

AETOSWire 2 October، 2023

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive license agreement with...

Read More Read more about Hikma and Cosmo partner on exclusive licensing agreement for Winlevi® (Clascoterone) for the Middle East and North Africa

Hoffmann Green Signs Its First Licensing Agreement in Saudi Arabia With the Shurfah Group

• .

Hoffmann Green Signs Its First Licensing Agreement in Saudi Arabia With the Shurfah Group

AETOSWire 5 September، 2023

CHAILLÉ-SOUS-LES-ORMEAUX, France — Hoffmann Green Cement Technologies (ISIN: FR0013451044, Mnemo: ALHGR) (Paris:ALHGR) (“Hoffmann Green Cement” or the...

Read More Read more about Hoffmann Green Signs Its First Licensing Agreement in Saudi Arabia With the Shurfah Group

Hikma and Rakuten Medical sign exclusive licensing agreement for AlluminoxTM platform cancer treatment for the Middle East and North Africa

• .

Hikma and Rakuten Medical sign exclusive licensing agreement for AlluminoxTM platform cancer treatment for the Middle East and North Africa

AETOSWire 11 August، 2023

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive licensing and...

Read More Read more about Hikma and Rakuten Medical sign exclusive licensing agreement for AlluminoxTM platform cancer treatment for the Middle East and North Africa

Adapt to Business Changes with Flexible Licensing

• .

Adapt to Business Changes with Flexible Licensing

NewsVoir 27 July، 2023

By John Maddison – EVP of Products and CMO at Fortinet Dubai, United Arab Emirates When it...

Read More Read more about Adapt to Business Changes with Flexible Licensing

Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region

• .

Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region

AETOSWire 3 January، 2023

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces a new exclusive licensing agreement...

Read More Read more about Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region

Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region

• .

Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region

AETOSWire 27 December، 2022

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces a new exclusive...

Read More Read more about Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region

Hikma and Celltrion Healthcare sign exclusive licensing agreement for ustekinumab for the Middle East and North Africa region

• .

Hikma and Celltrion Healthcare sign exclusive licensing agreement for ustekinumab for the Middle East and North Africa region

AETOSWire 30 November، 2022

London, England — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces a new exclusive licensing agreements with...

Read More Read more about Hikma and Celltrion Healthcare sign exclusive licensing agreement for ustekinumab for the Middle East and North Africa region